Cure My Disease

Don't miss your cure!

 Log in / Sign up

Talking it out: CBT may rewire Brain's response to body image fears

NCT ID NCT07016204

Symptom relief Sponsor: Istanbul Nisantasi University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether 12 weeks of Cognitive-Behavioral Therapy (CBT) can help people with Body Dysmorphic Disorder (BDD), a condition where someone is overly worried about small or imagined flaws in how they look. Sixty adults took part; half received weekly CBT sessions, while the other half were placed on a waitlist. Researchers used brainwave recordings, skin sensors, and eye-tracking to see if therapy changed brain activity, stress levels, and attention patterns when viewing their own face.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Jun 2025

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosed with Body Dysmorphic Disorder (BDD) according to DSM-5 criteria * Right-handed (to ensure consistency in EEG lateralization analyses) * Minimum education level of high school (for questionnaire comprehension) * Normal or corrected-to-normal vision (for eye-tracking calibration) * Willingness to participate in all therapy and assessment sessions * Signed written informed consent Exclusion Criteria: * Current use of psychotropic medication * Current or past psychotherapy within the last 6 months * Diagnosis of schizophrenia, bipolar disorder, or substance use disorder * Neurological disorders (e.g., epilepsy, traumatic brain injury) * Active suicidal ideation or recent suicide attempt (within past 12 months) * Pregnancy (due to possible changes in physiological readings) * Any uncorrected visual impairments or eye conditions preventing eye-tracking * Presence of metal implants or devices incompatible with EEG recording

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Body dysmorphic disorder are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

body dysmorphic disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Body dysmorphic disorder

Contacts and locations

Locations

  • Üsküdar University

    Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.